Cost impact of sobering centers on national health care spending in the United States.

Alcohol intoxication Alcohol use disorder Budget impact Emergency department Health care costs Sobering center

Journal

Translational behavioral medicine
ISSN: 1613-9860
Titre abrégé: Transl Behav Med
Pays: England
ID NLM: 101554668

Informations de publication

Date de publication:
08 10 2020
Historique:
pubmed: 23 5 2019
medline: 19 8 2021
entrez: 23 5 2019
Statut: ppublish

Résumé

Acute alcohol intoxication is responsible for a sizable share of emergency department visits. Intoxicated individuals without other medical needs may not require the high level of care provided by an emergency department. We estimate the impact on U.S. health care spending if individuals with uncomplicated, acute alcohol intoxication were treated in sobering centers instead of the emergency department. We performed a budget impact analysis from the perspective of the U.S. health care system based on published and gray literature reports. Ninety-five percent confidence intervals (CI) were estimated using Monte Carlo modeling with random variation for three variables (cost of an emergency department visit, cost of a sobering center visit, and start-up costs per sobering center visit) and the percentage of cases diverted from emergency departments to sobering centers. Outcomes were expressed in terms of national savings in 2017 U.S. dollars. Assuming a diversion rate of 50% based on previous studies, national savings range from $230 million to $1.0 billion annually. In the Monte Carlo modeling, we found annual national savings of $99.02 million (95% CI: $95.89-$102.19 million), $792.34 million (95% CI: $767.09-$817.58 million), and $1,185.51 million (95% CI: $1,150.64-$1,226.37 million) with diversion rates of 5%, 40%, and 60%, respectively. Implementing sobering centers as a treatment alternative for individuals with uncomplicated acute alcohol intoxication could yield substantial cost savings for the U.S. health care system.

Identifiants

pubmed: 31116401
pii: 5497397
doi: 10.1093/tbm/ibz075
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

998-1003

Informations de copyright

© Society of Behavioral Medicine 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Claudia Scheuter (C)

Clinical Excellence Research Center, Stanford University, Stanford, CA, USA.
Division of General Internal Medicine, Inselspital University Hospital, Bern, Switzerland.

Danielle H Rochlin (DH)

Clinical Excellence Research Center, Stanford University, Stanford, CA, USA.

Chuan-Mei Lee (CM)

Clinical Excellence Research Center, Stanford University, Stanford, CA, USA.

Arnold Milstein (A)

Clinical Excellence Research Center, Stanford University, Stanford, CA, USA.

Robert M Kaplan (RM)

Clinical Excellence Research Center, Stanford University, Stanford, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH